Sign In / Join

favorite Donate

close

person Sign In / Create Account

Treatment & Testing

Events you can join that educate on your necessary and potential treatment and testing.

Popular All Categories Navigating Your Health Treatment & Testing Financial Assistance Q&A HealthTree Research Community Days HealthTree Roundtables Support Demographic

Upcoming Events Past Events

El Rol del Tratamiento de Mantenimiento en Remisión para Mieloma Múltiple image

El Rol del Tratamiento de Mantenimiento en Remisión para Mieloma Múltiple

Oct 09, 2024

Oct 09, 2024 / 05:00PM - 06:00PM EDT

Comunidad de mieloma hispanohablante

How Personalized Is Multiple Myeloma Treatment and How Is That Changing? Introducing the Individual Risk Model for Myeloma image

How Personalized Is Multiple Myeloma Treatment and How Is That Changing? Introducing the Individual Risk Model for Myeloma

Oct 09, 2024

Oct 09, 2024 / 10:30AM - 11:30AM EDT

Relapsed/Refractory Myeloma

Pursuing Deeper Responses With Linvoseltamab in Newly Diagnosed Multiple Myeloma Patients image

Pursuing Deeper Responses With Linvoseltamab in Newly Diagnosed Multiple Myeloma Patients

Oct 07, 2024

Oct 07, 2024 / 02:00PM - 03:00PM EDT

Newly Diagnosed Myeloma

Talquetamab Side Effect Management image

Talquetamab Side Effect Management

Sep 17, 2024

Sep 17, 2024 / 04:00PM - 05:00PM EDT

Relapsed/Refractory Myeloma

Patient Panel: Preparing for a SCT: What do I need to bring/know? image

Patient Panel: Preparing for a SCT: What do I need to bring/know?

Sep 16, 2024

Sep 16, 2024 / 02:00PM - 03:00PM EDT

Stem Cell Transplant

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics. image

Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.

Aug 20, 2024

Aug 20, 2024 / 06:00PM - 07:00PM EDT

Immunotherapy (CAR T, Bispecifics and more) Treatment

The Efficacy of CAR-T Therapy in High-Risk Patients; and Strategies to Improve Outcomes image

The Efficacy of CAR-T Therapy in High-Risk Patients; and Strategies to Improve Outcomes

Jul 22, 2024

Jul 22, 2024 / 06:00PM - 07:00PM EDT

Plasma Cell Leukemia Community

Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami

Jul 15, 2024

Jul 15, 2024 / 11:00AM MDT

HealthTree Podcast for Multiple Myeloma

A patient's perspective: Vicki shares her experience with bispecifics and antibody drug conjugates image

A patient's perspective: Vicki shares her experience with bispecifics and antibody drug conjugates

Jul 03, 2024

Jul 03, 2024 / 01:00PM - 02:00PM EDT

Non-Secretory Myeloma Community

Is MRD Negativity the Goal of Myeloma Treatment? image

Is MRD Negativity the Goal of Myeloma Treatment?

Jun 18, 2024

Jun 18, 2024 / 01:00PM - 02:00PM EDT

Minimal Residual Disease (MRD)

Trending Articles

What Is the Prognosis of a Multiple Myeloma Patient?

Michele's Story: Beating the Odds with Multiple Myeloma

What Are Neutrophils in Multiple Myeloma?

IMS 2024: News for High-Risk Multiple Myeloma

IMS 2024: New Strategies Using Immunotherapies in Myeloma Care

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson

Sanofi

Pfizer

Genentech

Regeneron

Adaptive

Follow Us

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2024 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811